NTHI · Neonc Technologies Holdings, Inc.

Neonc Technologies Holdings, Inc. (NTHI) reported Q1 FY2026 results showing substantial year-over-year improvement in loss metrics, primarily driven by the normalization of advisory fees following the company's direct public listing. Revenue remained steady at $40.0K, consistent with the prior year as the Company focuses on clinical development rather than commercial revenue generation.

Operating income improved 81.2% to -$7.1M from -$37.6M, reflecting the absence of elevated Q1 2025 advisory expenses related to pre-listing activities. Management notes that advisory fee expense in Q1 2026 consisted of fees for capital financing arrangements pursuant to a letter of intent with AFH, a significant moderation from prior period levels tied to the listing process.

Net income followed suit, narrowing 76.8% to -$8.8M from -$38.0M, with diluted EPS improving 81.9% to -$0.38 from -$2.10. This loss reduction highlights the impact of non-recurring prior-year costs lapsing, though the Company continues to incur significant operating losses since inception, funded through equity and debt financings.

Cash flow from operations deteriorated to -$7.0M from -$5.7M year-over-year, pressured by working capital changes including increases in prepaid expenses and decreases in accrued compensation. Stock-based compensation, a non-cash item, did not impact cash position but contributed to expense recognition. Legal and professional expenses increased, reaching levels consistent with public company obligations such as 10-K filings, while general and administrative expenses saw reductions from lower marketing, rent, travel, and costs tied to a prior Middle East deal pursuit.

Liquidity remains a critical concern, with the Company expecting higher general and administrative costs to support expanding research and development, including future clinical programs, alongside public company compliance expenses. Future commercial and regulatory factors will influence clinical timelines. These dynamics underscore ongoing going concern risks as operations are sustained through external financing sources.